Viewing Study NCT01242527


Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2026-05-27 @ 2:22 AM
Study NCT ID: NCT01242527
Status: COMPLETED
Last Update Posted: 2016-08-04
First Post: 2010-11-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Epanova® for Lowering Very High Triglycerides
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Hypertriglyceridemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dyslipidemia View
None hyperlipidemia View
None omega-3 carboxylic acid View